Page results
-
This page provides information about anaesthesia for children having proton beam therapy.
-
UCLH today marks International Clinical Trials Day, which this year coincides with the National Institute for Health Research (NIHR) campaign encouraging everyone to ‘Be Part of Research.’
-
The service includes diagnosis, quantifying the degree of hearing loss, and rehabilitation of hearing impairment to limit participation restriction.
-
HTD Outpatients offers a wide range of clinics for Chagas disease, Infectious diseases, Leishmaniasis, Leprosy , Malaria , Microbiology, Neglected tropical diseases, Parasitology
-
This page explains what parathyroid surgery is and gives some information about what it involves.
-
The Maternal Medicine team provides care for women with pre-existing medical disorders or pregnancy-related medical conditions. We work in a multidisciplinary team of doctors and midwives in order to provide the best standard of care for women and their babies.
-
This page answers common questions about Acute Pancreatitis and how it is managed in North Central London (NCL).
-
Information about energy conservation for UCLH patients with mitochondrial disease.
-
The world’s largest-ever clinical trial of treatments to slow or stop the progression of Parkinson’s disease has launched at UCLH,
-
Patient information leaflet for Functional Electrical Stimulation (FES) Clinic
File results
-
FOI/2024/0403 - Risk Policy and corporate risk register
-
FOI/2024/0406 - Staff and patient discrimination complaints in 2021, 2022 and 2023
-
FOI/2024/0409 - Number of A&E attendees with mental health complaints from 2022 to 2024
-
FOI/2024/0412 - Healthcare travel costs scheme for patients
-
FOI/2024/0415 - Biologic and targeted medications within dermatology medicine
-
FOI/2024/0416 - Home dialysis treatment
-
FOI/2024/0417 - Funding for point-of-care home blood monitoring devices for cancer patients
-
FOI/2024/0420 - Commercialisation of NHS patient data
-
FOI/2024/0421 - Capital staffing nurses/ approved framework agencies/ escalated rates
-
FOI/2024/0423 - Giant cell arteritis (GCA) patient treatment